1. 2018
  2. Construction of High-Quality Camel Immune Antibody Libraries

    Romão, E., Poignavent, V., Vincke, C., Ritzenthaler, C., Muyldermans, S. & Monsion, B., 2018, In : Methods in Molecular Biology. 1701, p. 169-187 19 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Glioblastoma-specific anti-TUFM nanobody for in vitro immunoimaging and cancer stem cell targeting

    Samec, N., Jovcevska, I., Stojan, J., Zottel, A., Liovic, M., Myers, M. P., Muyldermans, S., Sribar, J., Krizaj, I. & Komel, R., 2018, In : Oncotarget. 9, 25, p. 17282-17299 18 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Guided evolution of recombinant Bombyx more acetylcholinesterase II by homology modelling to change pesticide sensitivity

    Cai, J., Wang, B., Chen, J., Rao, M., Muyldermans, S., Hua, X., Xie, X., Wang, H., Yang, J., Xu, Z., Shen, Y. & Sun, Y., 2018, In : International Journal of Molecular Sciences. 19, 11, p. pii E3366

    Research output: Contribution to journalArticleResearchpeer-review

  5. Nanobodies against EGFblocking the oncogenic activation of EGFR

    Guardiola, S., Varese, M., Sanchez-Navarro, M., Vincke, C., Teixido, M., Garcia, J., Muyldermans, S. & Giralt, E., 2018, In : Angewandte Chemie. 57, 42, p. 13843-13847

    Research output: Contribution to journalArticleResearchpeer-review

  6. Nanobodies as novel agents in envenomation therapy

    Alirahimi, E., Kazemi-Lomedasht, F., Shahbazzadeh, D., Habibi Anbouhi, M., Hosseinininejad-Chafi, M., Sotoudeh, N., Ghaderi, H., Muyldermans, S. & Behdani, M., 2018, In : BBA General Subjects. 1862, 12, p. 2955-2965 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Site-Specific Radioactive Labeling of Nanobodies

    Crauwels, M., Massa, S., Martin, C., Betti, C., Ballet, S., Devoogdt, N., Xavier, C. & Muyldermans, S., 2018, In : Methods in Molecular Biology. 1827, p. 505-540 36 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. The structural basis of nanobody unfolding reversibility and thermoresistance

    Kunz, P., Zinner, K., Mücke, N., Bartoschik, T., Muyldermans, S. & Hoheisel, J. D., 2018, In : Scientific Reports - Nature. 8, 1, p. 7934 7934.

    Research output: Contribution to journalArticleResearchpeer-review

  9. 2017
  10. Inhibiting the Ca 2+ Influx Induced by Human CSF

    Drews, A., De, S., Flagmeier, P., Wirthensohn, D. C., Chen, W-H., Whiten, D. R., Rodrigues, M., Vincke, C., Muyldermans, S., Paterson, R. W., Slattery, C. F., Fox, N. C., Schott, J. M., Zetterberg, H., Dobson, C. M., Gandhi, S. & Klenerman, D., 12 Dec 2017, In : Cell Reports. 21, 11, p. 3310-3316 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

  11. Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers

    Arezumand, R., Alibakhshi, A., Ranjbari, J., Ramazani, A. & Muyldermans, S., 8 Dec 2017, In : Frontiers in Immunology. 8, DEC, p. 1746 1746.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  12. Nanobodies targeting conserved epitopes on the major outer membrane protein of Campylobacter as potential tools for control of Campylobacter colonization

    Vanmarsenille, C., Díaz Del Olmo, I., Elseviers, J., Hassanzadeh Ghassabeh, G., Moonens, K., Vertommen, D., Martel, A., Haesebrouck, F., Pasmans, F., Hernalsteens, J-P. & De Greve, H., 8 Dec 2017, In : Veterinary Research. 48, 1, 14 p., 86.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...67 Next